Loss of CIITA and MHC Class II Expression in Diffuse Large B-Cell Lymphoma Is Not Explained by Methylation of CIITA Promoters III and IV

被引：0
|
作者：
Wilkinson, Sarah T. [1 ]
Fernandez, Diane R. [1 ]
Murphy, Shawn P. [2 ]
Chan, Wing C. [3 ]
Gascoyne, Randy D. [4 ]
Campo, Elias [5 ]
Jaffe, Elaine S. [6 ]
Staudt, Louis M. [6 ]
Delabie, Jan [7 ]
Rosenwald, Andreas [8 ]
Riinsza, Lisa M. [1 ]
机构：
[1] Univ Arizona, Tucson, AZ USA
[2] Univ Rochester, Sch Med & Dent, Rochester, NY USA
[3] Univ Nebraska, Med Ctr, Omaha, NE USA
[4] British Columbia Canc Agcy, Vancouver, BC V5Z 4E6, Canada
[5] Univ Barcelona, Barcelona, Spain
[6] Natl Canc Inst, Bethesda, MD USA
[7] Radium Hosp, Oslo, Norway
[8] Univ Wurzburg, Wurzburg, Germany
来源：
BLOOD | 2008年 / 112卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：631 / 631
页数：1
相关论文
共 50 条
  • [1] Histone deacetylase inhibitors activate CIITA and MHC class II antigen expression in diffuse large B-cell lymphoma
    Cycon, Kelly A.
    Mulvaney, Kathleen
    Rimsza, Lisa M.
    Persky, Daniel
    Murphy, Shawn P.
    IMMUNOLOGY, 2013, 140 (02) : 259 - 272
  • [2] Alterations in CIITA constitute a common mechanism accounting for downregulation of MHC class II expression in diffuse large B-cell lymphoma (DLBCL)
    Cycon, Kell A.
    Rimsza, Lisa M.
    Murphy, Shawn P.
    EXPERIMENTAL HEMATOLOGY, 2009, 37 (02) : 184 - 194
  • [3] Genetic Alterations of the MHC Class II Transactivator CIITA Are Frequent in Primary Mediastinal Large B-Cell Lymphoma and Associated with Diminished MHC Class II Expression
    Mottok, Anja
    Woolcock, Bruce W.
    Chan, Fong Chun
    Telenius, Adele
    Chavez, Elizabeth A.
    Boyle, Merrill
    Ben-Neriah, Susana
    Rimsza, Lisa M.
    Siebert, Reiner
    Gascoyne, Randy D.
    Steidl, Christian
    BLOOD, 2014, 124 (21)
  • [4] MHC Class II Transactivator (CIITA) Abnormalities Are Frequent in B-cell Lineage Lymphomas and Are Associated With Loss of MHC Class II (MHCII) Expression
    Jelloul, Fatima Zahra
    Pichardo, Janine D.
    Khattar, Pallavi
    Ananthamurthy, Anuradha
    Rao, Mamta
    Areeyqur, Ruth
    Jungbluth, Achim
    Wang, Lu
    Zhang, Yanming
    Dogan, Ahmet
    LABORATORY INVESTIGATION, 2018, 98 : 525 - 525
  • [5] Decreased major histocompatibility complex class II expression in diffuse large B-cell lymphoma does not correlate with CpG methylation of class II transactivator promoters III and IV
    Wilkinson, Sarah T.
    Fernandez, Diane R.
    Murphy, Shawn P.
    Braziel, Rita M.
    Campo, Elias
    Chan, Wing C.
    Delabie, Jan
    Gascoyne, Randy D.
    Staudt, Louis M.
    Jaffe, Elaine S.
    Rosenwald, Andreas
    Rimsza, Lisa M.
    LEUKEMIA & LYMPHOMA, 2009, 50 (11) : 1875 - U187
  • [6] Low Expression of the CIITA Gene Predicts Poor Outcome in Diffuse Large B-Cell Lymphoma
    Autio, Matias
    Jantti, Kirsi
    Cervera, Alejandra
    Hautaniemi, Sampsa
    Leppa, Sirpa
    BLOOD, 2016, 128 (22)
  • [7] MHC Class II Transactivator (CIITA) Abnormalities Are Frequent in B-cell Lineage Lymphomas and Are Associated With Loss of MHC Class II (MHCII)
    Jelloul, Fatima Zahra
    Pichardo, Janine D.
    Khattar, Pallavi
    Ananthamurthy, Anuradha
    Rao, Mamta
    Areeyqur, Ruth
    Jungbluth, Achim
    Wang, Lu
    Zhang, Yanming
    Dogan, Ahmet
    MODERN PATHOLOGY, 2018, 31 : 525 - 525
  • [8] Genomic Alterations in CIITA Are Frequent in Primary Mediastinal Large B Cell Lymphoma and Are Associated with Diminished MHC Class II Expression
    Mottok, Anja
    Woolcock, Bruce
    Chan, Fong Chun
    Tong, King Mong
    Chong, Lauren
    Farinha, Pedro
    Le Telenius, Ade
    Chavez, Elizabeth
    Ramchandani, Suvan
    Drake, Marie
    Boyle, Merrill
    Ben-Neriah, Susana
    Scott, David W.
    Rimsza, Lisa M.
    Siebert, Reiner
    Gascoyne, Randy D.
    Steidl, Christian
    CELL REPORTS, 2015, 13 (07): : 1418 - 1431
  • [9] MHC class II as a therapeutic target in B-cell lymphomas: the CIITA road to paradise?
    Diepstra, Arjan
    LEUKEMIA & LYMPHOMA, 2009, 50 (11) : 1740 - 1741
  • [10] HLA-G and MHC Class II Protein Expression in Diffuse Large B-Cell Lymphoma
    Dorota Jesionek-Kupnicka
    Marcin Bojo
    Monika Prochorec-Sobieszek
    Anna Szumera-Ciećkiewicz
    Joanna Jabłońska
    Ewa Kalinka-Warzocha
    Radzisław Kordek
    Wojciech Młynarski
    Tadeusz Robak
    Krzysztof Warzocha
    Ewa Lech-Maranda
    Archivum Immunologiae et Therapiae Experimentalis, 2016, 64 : 225 - 240
12345